Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 12, Issue 29, 2006, Pages 4716-4720

  Spadaro, Aldo ^a   Ajello, Antonino ^a   Luigiano, Carmelo ^a   Morace, Carmela ^a   Resta, Maria Letizia ^a   Berlinghieri, Grazia ^a   Campo, Salvatore ^a   Scisca, Claudio ^a   Alibrandi, Angela ^a   D'arrigo, Graziella ^a   Alessi, Nunziata ^a   Ferraù, Oscar ^a   Freni, Maria Antonietta ^a  

^a Clinica Medica I   (Italy)

Author keywords

Alpha fetoprotein; Hepatocellular carcinoma; Liver cirrhosis; Nociceptin orphanin FQ

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; AMYLASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CALCIUM; CHOLINESTERASE; CREATINE KINASE; CREATININE; FIBRINOGEN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN; LACTATE DEHYDROGENASE; NOCICEPTIN; POTASSIUM; SODIUM; UREA;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISCRIMINANT ANALYSIS; DISEASE CLASSIFICATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN CELL; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONPARAMETRIC TEST; PREDICTION; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT;

EID: 33747712070     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i29.4716     Document Type: Article

References (28)

1. Calo' G, Guerrini R, Rizzi A, Salvadori S, Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br J Pharmacol 2000; 129: 1261-1283
2. Mogil JS, Pasternak GW. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev 2001; 53: 381-415
3. Spampinato S, Di Toro R, Qasem AR. Nociceptin-induced internalization of the ORL1 receptor in human neuroblastoma cells. Neuroreport 2001; 12: 3159-3163
4. Ko MH, Kim YH, Woo RS, Kim KW. Quantitative analysis of nociceptin in blood of patients with acute and chronic pain. Neuroreport 2002; 13: 1631-1633
5. Hantos MB, Szalay F, Lakatos PL, Hegedus D, Firneisz G, Reiczigel J, Torok T, Tekes K. Elevated plasma nociceptin level in patients with Wilson disease. Brain Res Bull 2002; 58: 311-313
6. Szalay F, Hantos MB, Horvath A, Lakatos PL, Folhoffer A, Dunkel K, Hegedus D, Tekes K. Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma. World J Gastroenterol 2004; 10: 42-45
7. Benvegnu L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 2004; 53: 744-749
8. Daniele B, Bencivenga A, Megna AS, Tinessa V. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 2004; 127: S108-S112
9. Aoyagi Y, Oguro M, Yanagi M, Mita Y, Suda T, Suzuki Y, Hata K, Ichii K, Asakura H. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma. Cancer 1996; 77: 1781-1786
10. Yamagamim H, Moriyama M, Matsumura H, Aoki H, Shimizu T, Saito T, Kaneko M, Shioda A, Tanaka N, Arakawa Y. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral liver diseases. Cancer 2002; 95: 824-834
11. Spadaro A, Ajello A, Morace C, Zirilli A, D'arrigo G, Luigiano C, Martino F, Bene A, Migliorato D, Turiano S, Ferrau O, Freni MA. Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. World J Gastroenterol 2005; 11: 1987-1990
12. Chen PY, Popovich PM. Correlation: Parametric and nonparametric measures. Thousand Oaks, CA: Sage Publications, 2002
13. Pesarin F. Multivariate permutation tests: with application in biostatistic. Chichester, New York, Weinheim, Brisbane, Singapore, Toronto: John Wiley & sons, LTD 2001
14. Härdle W, Simar L. Applied Multivariate Statistical Analysis, Springer-Verlag, Berlin, Heidelberg New York, Hong Kong, London, Milan, Paris, Tokyo, 2003
15. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108
16. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917
17. Kim CK, Lim JH, Lee WJ. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients. J Ultrasound Med 2001; 20: 99-104
18. McIntire KR, Waldmann TA, Moertel CG, Go VL. Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res 1975; 35: 991-996
19. Bayati N, Silverman AL, Gordon SC. Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C. Am J Gastroenterol 1998; 93: 2452-2436
20. Nguyen MH, Garcia RT, Simpson PW, Wright TL, Keeffe EB. Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology 2002; 36: 410-417
21. Wang JB, Johnson PS, Imai Y, Persico AM, Ozenberger BA, Eppler CM, Uhl GR. cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett 1994; 348:75-79
22. Xie GX, Ito E, Maruyama K, Suzuki Y, Sugano S, Sharma M, Pietruck C, Palmer PP. The promoter region of human prepronociceptin gene and its regulation by cyclic AMP and steroid hormones. Gene 1999; 238:427-436
23. Horvath A, Folhoffer A, Lakatos PL, Halosz J, Illyes G, Schaff Z, Hantos MB, Tekes K, Szalay F. Rising plasma nociceptin level during development of HCC: a case report. World J Gastroenterol 2004; 10: 152-154
24. Horvath A, Folhoffer A, Csak T, Lakatos PL, Zalatnai A, Hantos MB, Tekes K, Szalay F. Increased nociceptin and nocistatin in plasma, cerebrospinal fluid and tumor tissue indicates altered opioid system in rats with experimental hepatocellular carcinoma. J Hepatol 2004; 40 S1: 79 AB 250
25. Fiset ME, Gilbert C, Poubelle PE, Pouliot M. Human neutrophils as a source of nociceptin: a novel link between pain and inflammation. Biochemistry 2003; 42: 10498-10505
26. Serhan CN, Fierro IM, Chiang N, Pouliot M. Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4. J Immunol 2001; 166: 3650-3654
27. Schlicker E, Morari M. Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system. Peptides 2000; 21: 1023-1029
28. Helyes Z, Nemeth J, Pinter E, Szolcsanyi J. Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals. Br J Pharmacol 1997; 121: 613-615